ASTERA LABS INC (ALAB) Stock Fundamental Analysis

NASDAQ:ALAB • US04626A1034

126.32 USD
-2.08 (-1.62%)
Last: Feb 25, 2026, 01:14 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALAB. ALAB was compared to 114 industry peers in the Semiconductors & Semiconductor Equipment industry. ALAB is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALAB shows excellent growth, but is valued quite expensive already. These ratings could make ALAB a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • ALAB had positive earnings in the past year.
  • ALAB had a positive operating cash flow in the past year.
ALAB Yearly Net Income VS EBIT VS OCF VS FCFALAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 14.31%, ALAB belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
  • ALAB has a Return On Equity of 16.07%. This is amongst the best in the industry. ALAB outperforms 81.58% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.79%, ALAB belongs to the top of the industry, outperforming 80.70% of the companies in the same industry.
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROIC 9.79%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALAB Yearly ROA, ROE, ROICALAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • The Profit Margin of ALAB (25.70%) is better than 84.21% of its industry peers.
  • With a decent Operating Margin value of 20.34%, ALAB is doing good in the industry, outperforming 78.95% of the companies in the same industry.
  • ALAB's Gross Margin of 75.69% is amongst the best of the industry. ALAB outperforms 94.74% of its industry peers.
  • In the last couple of years the Gross Margin of ALAB has remained more or less at the same level.
Industry RankSector Rank
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
ALAB Yearly Profit, Operating, Gross MarginsALAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALAB is destroying value.
  • Compared to 1 year ago, ALAB has more shares outstanding
  • ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALAB Yearly Shares OutstandingALAB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
ALAB Yearly Total Debt VS Total AssetsALAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 79.27 indicates that ALAB is not in any danger for bankruptcy at the moment.
  • ALAB has a better Altman-Z score (79.27) than 98.25% of its industry peers.
  • ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 79.27
ROIC/WACC0.92
WACC10.7%
ALAB Yearly LT Debt VS Equity VS FCFALAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 10.24 indicates that ALAB has no problem at all paying its short term obligations.
  • ALAB has a Current ratio of 10.24. This is amongst the best in the industry. ALAB outperforms 93.86% of its industry peers.
  • A Quick Ratio of 9.79 indicates that ALAB has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 9.79, ALAB belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.24
Quick Ratio 9.79
ALAB Yearly Current Assets VS Current LiabilitesALAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

  • ALAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.00%, which is quite impressive.
  • ALAB shows a strong growth in Revenue. In the last year, the Revenue has grown by 115.13%.
  • ALAB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 120.18% yearly.
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%

3.2 Future

  • Based on estimates for the next years, ALAB will show a very strong growth in Earnings Per Share. The EPS will grow by 25.00% on average per year.
  • ALAB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.33% yearly.
EPS Next Y30.96%
EPS Next 2Y34.29%
EPS Next 3Y38.21%
EPS Next 5Y25%
Revenue Next Year60.49%
Revenue Next 2Y48.53%
Revenue Next 3Y41.59%
Revenue Next 5Y19.33%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALAB Yearly Revenue VS EstimatesALAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
ALAB Yearly EPS VS EstimatesALAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

  • ALAB is valuated quite expensively with a Price/Earnings ratio of 68.65.
  • The rest of the industry has a similar Price/Earnings ratio as ALAB.
  • The average S&P500 Price/Earnings ratio is at 26.98. ALAB is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 52.42, which means the current valuation is very expensive for ALAB.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALAB is on the same level as its industry peers.
  • ALAB is valuated expensively when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 68.65
Fwd PE 52.42
ALAB Price Earnings VS Forward Price EarningsALAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALAB.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALAB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 75.72
EV/EBITDA 108.05
ALAB Per share dataALAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ALAB's earnings are expected to grow with 38.21% in the coming years.
PEG (NY)2.22
PEG (5Y)N/A
EPS Next 2Y34.29%
EPS Next 3Y38.21%

0

5. Dividend

5.1 Amount

  • ALAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ASTERA LABS INC

NASDAQ:ALAB (2/25/2026, 1:14:07 PM)

126.32

-2.08 (-1.62%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-04
Inst Owners76.83%
Inst Owner Change2.67%
Ins Owners11.28%
Ins Owner Change-9.4%
Market Cap21.34B
Revenue(TTM)852.52M
Net Income(TTM)219.13M
Analysts80.71
Price Target207.65 (64.38%)
Short Float %7.12%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.96%
Min EPS beat(2)10.58%
Max EPS beat(2)23.34%
EPS beat(4)4
Avg EPS beat(4)20.27%
Min EPS beat(4)10.58%
Max EPS beat(4)33.19%
EPS beat(8)8
Avg EPS beat(8)91.39%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.89%
Min Revenue beat(2)6.34%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)6.73%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)8
Avg Revenue beat(8)8.2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.82%
PT rev (3m)1.89%
EPS NQ rev (1m)3.48%
EPS NQ rev (3m)3.59%
EPS NY rev (1m)0%
EPS NY rev (3m)13.19%
Revenue NQ rev (1m)12.76%
Revenue NQ rev (3m)13.98%
Revenue NY rev (1m)11.37%
Revenue NY rev (3m)27.08%
Valuation
Industry RankSector Rank
PE 68.65
Fwd PE 52.42
P/S 25.03
P/FCF 75.72
P/OCF 66.82
P/B 15.65
P/tB 15.65
EV/EBITDA 108.05
EPS(TTM)1.84
EY1.46%
EPS(NY)2.41
Fwd EY1.91%
FCF(TTM)1.67
FCFY1.32%
OCF(TTM)1.89
OCFY1.5%
SpS5.05
BVpS8.07
TBVpS8.07
PEG (NY)2.22
PEG (5Y)N/A
Graham Number18.28
Profitability
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROCE 12.4%
ROIC 9.79%
ROICexc 65.25%
ROICexgc 65.25%
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
FCFM 33.05%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 549.77%
Cap/Sales 4.4%
Interest Coverage 250
Cash Conversion 177.14%
Profit Quality 128.58%
Current Ratio 10.24
Quick Ratio 9.79
Altman-Z 79.27
F-Score6
WACC10.7%
ROIC/WACC0.92
Cap/Depr(3y)596.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
EPS Next Y30.96%
EPS Next 2Y34.29%
EPS Next 3Y38.21%
EPS Next 5Y25%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%
Revenue Next Year60.49%
Revenue Next 2Y48.53%
Revenue Next 3Y41.59%
Revenue Next 5Y19.33%
EBIT growth 1Y249.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.46%
EBIT Next 3Y43.48%
EBIT Next 5Y29.17%
FCF growth 1Y175.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.62%
OCF growth 3YN/A
OCF growth 5YN/A

ASTERA LABS INC / ALAB FAQ

Can you provide the ChartMill fundamental rating for ASTERA LABS INC?

ChartMill assigns a fundamental rating of 6 / 10 to ALAB.


Can you provide the valuation status for ASTERA LABS INC?

ChartMill assigns a valuation rating of 2 / 10 to ASTERA LABS INC (ALAB). This can be considered as Overvalued.


How profitable is ASTERA LABS INC (ALAB) stock?

ASTERA LABS INC (ALAB) has a profitability rating of 5 / 10.


Can you provide the financial health for ALAB stock?

The financial health rating of ASTERA LABS INC (ALAB) is 8 / 10.